| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 10.203 | 51.625 | 8.120 | 38.877 | 83.207 | 91.930 | 80.193 | 107.258 |
| Total Income - EUR | - | - | 10.226 | 52.026 | 8.387 | 39.141 | 83.326 | 92.849 | 82.569 | 109.280 |
| Total Expenses - EUR | - | - | 739 | 1.742 | 1.260 | 1.480 | 1.203 | 3.356 | 11.981 | 12.609 |
| Gross Profit/Loss - EUR | - | - | 9.487 | 50.284 | 7.128 | 37.661 | 82.123 | 89.493 | 70.588 | 96.671 |
| Net Profit/Loss - EUR | - | - | 9.180 | 48.736 | 6.881 | 36.573 | 79.675 | 87.244 | 69.788 | 93.906 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Innuevo Lab Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 9.914 | 49.563 | 6.966 | 37.007 | 82.588 | 91.152 | 74.148 | 114.743 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 7.905 | 40.145 | 1.036 | 0 | 0 | 65.498 | 53.250 | 14.284 |
| Cash | - | - | 2.009 | 9.418 | 5.929 | 37.007 | 82.587 | 25.654 | 2.703 | 5.901 |
| Shareholders Funds | - | - | 9.224 | 48.787 | 6.932 | 36.622 | 79.723 | 87.293 | 69.836 | 110.399 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 730 | 776 | 34 | 385 | 2.864 | 3.859 | 4.312 | 4.344 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6201 - 6201" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Innuevo Lab Srl